A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2004
11/04/2004	US20040220283 Aqueous 2,6-diisopropylphenol pharmaceutical compositions
11/04/2004	US20040220282 Animal repellent formulation and method for preparing the same
11/04/2004	US20040220281 administering diphenyl compound; following sufficient time to permit inhibition of binding of intracellular histamine, subsequently administering a chemotherapeutic agent active in hormone-refractory prostate cancer
11/04/2004	US20040220280 Sertraline hydrochloride polymorphs
11/04/2004	US20040220277 Enantiomeric amphetamine compositions
11/04/2004	US20040220276 Coated granules of allylamine-or benzylamine-anti-mycotics
11/04/2004	US20040220274 Synergistic mixture of neurokinin receptor antagonist and phosphodiesterase inhibitor
11/04/2004	US20040220273 Preparation of 2-aminomethyl-5-fluorobenzamides
11/04/2004	US20040220270 Methods and composition of treating glaucoma by modulating tyrosinase/L-DOPA pathway
11/04/2004	US20040220269 SUPPRESSING THYROID STIMULATING HORMONE (TSH) SECRETION WITHOUT PITUITARY SPECIFIC MONODEIODINASE TYPE II INHIBITION BY ADMINISTRATION OF TETRAC, METABOLITE OF THYROXINE; for suppressing growth of residual thyroid tissue in a patient post thyroidectomy
11/04/2004	US20040220268 2,4,6-Trimethyl-N-(meta 3-trifluoromethyl-phenyl)-benzenesulfonamide; activate the phospholipase C activity, and then contacting the cell with a compound to determine whether phospholipase C activity is inhibited, wherein inhibition indicates that the compound is an anti-tumor agent candidate
11/04/2004	US20040220267 Derivatives of pentacyclic nortriterpene quinone methides as compounds useful in the treatment of inflammatory, neurodegenerative, and neoplastic diseases
11/04/2004	US20040220266 Orally administering calcium or magnesium 3-hydroxy-3-methylbutyrate; treating osteoporosis, hypertension and bone loss
11/04/2004	US20040220265 Contacting mammalian cells with nitric oxide mediator, wherein nitric oxide mediator is selected from pyruvates, pyruvate precursors, alpha -keto acids having four or more carbon atoms, precursors of alpha -keto acids for therapy
11/04/2004	US20040220264 Bioavailability and improved delivery of acidic pharmaceutical drugs
11/04/2004	US20040220263 Dicreatine Malate
11/04/2004	US20040220262 Transdermal and topical administration of drugs using basic permeation enhancers
11/04/2004	US20040220261 Cycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals
11/04/2004	US20040220260 efficacious in producing nitric oxide in the skin, the mucous membranes or the scalp; treatment of psoriasis lesions and/or chronic ulcers; i.e. Ascorbyl 2-O-cinnamate
11/04/2004	US20040220259 treating dermatological disorders that involve or affect vascular tissues present in skin, including blood vessels and capillaries by topically applying, for example, a polyhydroxy-aldonic acid, a polyhydroxy-aldonic lactone, and an organic acid lactone having two or more hydroxyl or ketohydroxyl groups
11/04/2004	US20040220258 use of 3-(4-Hydroxy-2-oxo-2H-chromen-3-yl)-3-phenyl-propionic acid, 3-(4-Hydroxy-2-oxo-2H-chromen-3-yl)-3-phenyl-propionic acid methyl ester, for example, as anticoagulants
11/04/2004	US20040220257 modulating the activity of the mitochrondrial permeability transition pore complex comprising exposing said complex to compound such as Spiro [Cyclopentane-1,5'-[5H]Dibenzo [a,d]Cyclohepten]-2-one, 10', 11'-dihydro-3-methylene-
11/04/2004	US20040220256 Formed as enantiomers of cis-beta-phenylglycidic acid/beta-phenylisoserine react with nitrile compound via ritter reaction
11/04/2004	US20040220254 Process for preparing 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl) ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide
11/04/2004	US20040220252 Novel crystalline forms of trandolapril
11/04/2004	US20040220251 Furanose-type bicyclic carbohydrates with biological activity
11/04/2004	US20040220250 Controlled release and delayed release formulations containing carvedilol; able to extend the duration of action of carvedilol, thus improving bioavailability; drug formulation comprises a hydrophilic polymer
11/04/2004	US20040220249 treating, preventing, or minimizing adhesion formation during or following a surgical procedure comprising administering to a patient in need thereof a therapeutically effective amount of at least one COX-2 inhibitor, wherein the COX-2 inhibitor is not nimesulide, but preferably is celecoxib
11/04/2004	US20040220246 2-imidazomethyl- pyrido(4,3-b)indol-1-one or -carbazol-1-one derivatives containing an ester group; especially for treating irritable bowel syndrome.
11/04/2004	US20040220244 PHOSPHOLIPASE INHIBITORS; use of inhibitor compositions in mammals to relieve sick conditions accompanied by enhanced PLA(2) activity such as inflammation, asthma, rhinitis, bronchitis, pneumonia, adult respiratory distress syndrome, inflammatory intestine disorder, Crohn's disease
11/04/2004	US20040220242 administering drug which suppress nitric oxide synthesis and antitrypsin drug
11/04/2004	US20040220241 Substituted biphenyl derivatives
11/04/2004	US20040220240 Method of increasing the extent of absorption of tizanidine
11/04/2004	US20040220239 Inhibitors of serine protease activity methods and compositions for treatment of nitric oxide-induced clinical conditions
11/04/2004	US20040220238 Pyrrolidine oxadiazole-and thiadiazole derivatives
11/04/2004	US20040220237 Asthma and allergic inflammation modulators
11/04/2004	US20040220236 4-Aryl quinols and analogs thereof as therapeutic agents
11/04/2004	US20040220235 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
11/04/2004	US20040220234 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase
11/04/2004	US20040220233 for treating p38 kinase-associated conditions; may be useful in treating inflammatory bowel disease, rheumatoid arthritis, psoriasis, multiple sclerosis, endotoxin shock, osteoporosis, Alzheimer's disease, and congestive heart failure
11/04/2004	US20040220231 Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activity
11/04/2004	US20040220230 transfroming growth factor antagonist; therapy for urogenital disorders, cardiovascular disorders
11/04/2004	US20040220228 Freeze-dried pantoprazole preparation and pantoprazole injection
11/04/2004	US20040220227 Remedies for allergic eye diseases
11/04/2004	US20040220225 Non-imidazole alkylamines as histamine H3-receptor ligands and their therapeutic applications
11/04/2004	US20040220224 administering a quaternary ammonium compound
11/04/2004	US20040220223 Novel human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them
11/04/2004	US20040220221 using antimalaria drugs such as melfloquine, hydroxychloroquine, chloroquinine, primaquinine, quinidine; administering by mouth; bone disorders
11/04/2004	US20040220220 Method for treating inflammatory bowel disease
11/04/2004	US20040220213 Zolpidem hemitartrate
11/04/2004	US20040220212 Zolpidem hemitartrate
11/04/2004	US20040220211 Zolpidem hemitartrate
11/04/2004	US20040220210 therapy of insomia, sleep disorders
11/04/2004	US20040220209 Novel imidazopyridine compounds with therapeutic effect
11/04/2004	US20040220208 Imidazopyridinones as p38 map kinase inhibitors
11/04/2004	US20040220207 Chemokine receptor binding heterocyclic compounds
11/04/2004	US20040220206 anticoagulants; antiinflammatory agents; cardiovascular disorders
11/04/2004	US20040220205 Parkinson's disease; restless leg syndrome; sexual disorders
11/04/2004	US20040220204 mixture of fatty ester, alkylene carbonate, butylene glycol, diethylene glycol, monoalkyl ether and thickeners
11/04/2004	US20040220203 Method and composition for potentiating an opiate analgesic
11/04/2004	US20040220202 antiinflammatory agents; central nervous system disorders; controlling cell proliferation, cell differentiation; anticancer agents; antidepressants
11/04/2004	US20040220200 Compositions useful as protein kinase inhibitors
11/04/2004	US20040220198 Methods for treating malaria by modulation of G protein function
11/04/2004	US20040220196 antitumor agents; 4-amino-5-fluoro-3-(6-( 4-methylpiperazin-1-yl)1H-benzimidazol-2-yl)-quinolin-2-one
11/04/2004	US20040220193 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound
11/04/2004	US20040220192 antiserotonine agents; central nervous system disorders; anxiolytic agents; attention deficit disorders; strokes; headaches
11/04/2004	US20040220190 Methods of treating metabolic syndrome using dopamine receptor agonists
11/04/2004	US20040220188 Alkylidene pyrazolidinedione derivatives
11/04/2004	US20040220187 Compositions of a cyclooxygenase-2 selective inhibitor and a sodium ion channel blocker for the treatment of pain, inflammation or inflammation mediated disorders
11/04/2004	US20040220185 antiinflammatory agents; antiarthritic agents; anticancer agents
11/04/2004	US20040220184 Pharmaceutical composition for the treatment of attention deficit hyperactivity disorder (ADHD)
11/04/2004	US20040220183 inhibiting tumor necrosis factor; respiratory system disorders; prevent neutrophil infiltration in lungs; skin disorders
11/04/2004	US20040220181 Adhesive antineoplastic compositions
11/04/2004	US20040220180 Compositions relating to novel compounds and targets thereof
11/04/2004	US20040220176 Particle-forming compositions containing fused pyrrolocarbazoles
11/04/2004	US20040220175 (Pyrido/thieno) - [f] - oxazepine-5-one derivatives
11/04/2004	US20040220174 for example, 1-(4-methoxyphenyl)-7-oxo-6-[5-(2-oxo-1-piperidinyl)2-pyridinyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide; use as anticoagulant agent for treatment of thromboembolic disorders
11/04/2004	US20040220173 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders
11/04/2004	US20040220171 anticoagulants; immunomoderators; antiinflammatory agents
11/04/2004	US20040220170 analgesics; reduction of pain
11/04/2004	US20040220169 anticoagulants; factor x inhibitor; N-[1-(5-chloro-1H-benzimidazol-2-yl)ethyl]-3-methyl-4-(2,5-dihydropyrrol-1-ylcarbonyl)benzamide
11/04/2004	US20040220168 Process for the preparation of imipenem
11/04/2004	US20040220167 Methods of treating neuralgic pain
11/04/2004	US20040220166 Half-sandwich ruthenium (II) compounds comprising nitrogen containing ligands ligands for treatment of cancer
11/04/2004	US20040220164 Triaza compound immunoregulatory agents
11/04/2004	US20040220163 Contraceptive method and composition
11/04/2004	US20040220162 Compounds useful in the manufacture of an anti-inflammatory androstane derivative
11/04/2004	US20040220161 using 6-bromo-3-hydroxyandrostan-17-one
11/04/2004	US20040220160 fine particle sizes; topical applying; mixture with arginine, tocopherol and lecithin
11/04/2004	US20040220159 osteoporosis, periodontal diseases, aging resistance, antilipemic agents, anticholesterol agents, canticancer agents, antiarthritic agents, sexual disorders
11/04/2004	US20040220157 a 3-oxoandrostrane carbothioic acid compound
11/04/2004	US20040220156 Novel anti-inflammatory androstane derivative compositions
11/04/2004	US20040220155 administering mixture of cyclooxygenase inhibitor and corticosteroid
11/04/2004	US20040220154 Topical testosterone formulations and associated methods
11/04/2004	US20040220153 Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
11/04/2004	US20040220152 administering dosage form containing mixture of estrogen and progestin
11/04/2004	US20040220151 Process for treating tissue and suppressing pain
11/04/2004	US20040220150 pure antibiotic
11/04/2004	US20040220149 Nerve cell survival promoters containing cyclic phosphatidic acid derivative
11/04/2004	US20040220148 5-Membered ring heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists

1 ... 4902 4903 4904 4905 4906 4907 4908 4909 4910 4911 4912 4913 4914 4915 4916 4917 4918 4919 4920 4921 4922 ... 7860